ArticleCancers2024

Reduced Dose of Post-Transplant Cyclophosphamide with Tacrolimus for the Prevention of Graft-versus-Host Disease in HLA-Matched Donor Peripheral Blood Stem Cell Transplants: A Prospective Pilot Study.

Alex Juárez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.